The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 571.00
Bid: 566.00
Ask: 576.00
Change: -10.00 (-1.72%)
Spread: 10.00 (1.767%)
Open: 575.00
High: 578.00
Low: 570.00
Prev. Close: 580.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Director/PDMR Shareholding

5 Feb 2021 07:00

RNS Number : 0800O
Marlowe PLC
05 February 2021
 

5 February 2021

 

Marlowe plc

 

Issue of Equity and Director/PDMR Shareholding

 

Marlowe plc ("Marlowe" or the "Group"), the UK leader in business critical services and software which assure safety and regulatory compliance announces that, pursuant to redemptions of all remaining historical awards under the Marlowe 2016 Incentive Scheme (the "2016 Scheme"), application has been made for 2,062,647 new ordinary shares of 50 pence each in the Group ("New Ordinary Shares") to be admitted to trading on AIM. As a result, the 2016 Scheme is now settled in full and no further new ordinary shares in the Group will be issued under it.

 

The New Ordinary Shares, issued at an effective issue price of 615 pence per New Ordinary Share, will rank pari-passu with existing ordinary shares and it is expected that admission will occur at 8.00 a.m. on 10 February 2021 ("Admission").

 

1,559,669 of the New Ordinary Shares have been issued to Alex Dacre, the Group's Chief Executive Officer, and 337,928 of the New Ordinary Shares have been issued to Charles Skinner, a Non-Executive Director of the Group. Messrs. Dacre and Skinner are therefore now beneficially interested in 5,094,352 Marlowe ordinary shares (representing c.8.2 per cent. of the Group's issued share capital) and 805,084 Marlowe ordinary shares (representing c.1.3 per cent. of the Group's issued share capital) respectively.

 

Following Admission of the New Ordinary Shares, the Group's issued ordinary share capital will comprise 62,477,095 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 62,477,095. The above figure of 62,477,095 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Group under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The notifications below, made in accordance with the Market Abuse Regulation, provide further details.

 

 

For further information:

 

Marlowe plc

www.marloweplc.com

Alex Dacre, Chief Executive

Tel: +44 (0) 203 841 6194

Mark Adams, Group Finance Director

IR@marloweplc.com

 

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Nicholas Wells

Tel: +44 (0)20 7397 8900

Ben Jeynes

 

 

Joh. Berenberg, Gossler & Co. KG, London Branch (Joint Broker)

Ben Wright

Tel: +44 (0)20 3207 7800

Mark Whitmore

 

 

 

FTI Consulting

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Alex Dacre

2. Charles Skinner

2

Reason for the notification

a)

Position/status

1. Chief Executive Officer

2. Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Issue of ordinary shares pursuant to Marlowe 2016 Incentive Scheme

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

1. 615 pence

 

2. 615 pence

1. 1,559,6692. 337,928

 

 

 

 

 

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

Single transactions

- Price

 

e)

Date of the transaction

4 February 2021

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZGGZRDKGMZM
Date   Source Headline
11th Mar 202011:24 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNSAcquisition of Solve HR Limited
9th Mar 20207:00 amRNSAcquisition of Managed Occupational Health Limited
3rd Feb 20207:00 amRNSAcquisition of Eurosafe UK Group Limited
24th Dec 201910:56 amRNSDirector/PDMR Shareholding
9th Dec 201911:25 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSAcquisition of Law At Work (Holdings) Limited
3rd Dec 20197:00 amRNSHalf Year Results FY 2020
2nd Dec 20197:00 amRNSAcquisition of FSE Fire Safety Systems Limited
18th Sep 20194:26 pmRNSDirector/PDMR Shareholding
18th Sep 20194:14 pmRNSResult of AGM
3rd Sep 20193:50 pmRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSAcquisition of Quantum Compliance
24th Jun 20191:39 pmRNSDirector/PDMR Shareholding
19th Jun 20193:36 pmRNSGrant of Share Options
18th Jun 20197:00 amRNSFinal Results
7th Jun 201911:21 amRNSResult of General Meeting
22nd May 20197:02 amRNSIssue of Equity
22nd May 20197:00 amRNSResults of the Placing
21st May 20194:36 pmRNSAcquisition and Proposed Placing
29th Apr 20197:00 amRNSTrading Update
10th Apr 20197:00 amRNSAppointment of Joint Broker
31st Jan 20197:00 amRNSAcquisition of Atana Limited
21st Jan 20197:00 amRNSDisposal of non-core assets
16th Jan 20193:36 pmRNSDirector/PDMR Shareholding
21st Dec 20187:00 amRNSAcquisition of William Martin
18th Dec 20182:15 pmRNSHolding(s) in Company
4th Dec 20187:01 amRNSHalf Year Results FY 2019
4th Dec 20187:00 amRNSAppointment of Chairman Designate
23rd Nov 20187:00 amRNSNew debt facility
22nd Oct 20187:00 amRNSAcquisition of Firecrest Services Limited
4th Oct 20187:00 amRNSAcquisition of Tersus Consultancy Limited
5th Sep 201810:46 amRNSResult of AGM
28th Aug 20187:00 amRNSAcquisition of Suez WCS Limited
30th Jul 20187:00 amRNSAcquisition of Kingfisher Environmental Services
16th Jul 201810:04 amRNSHolding(s) in Company
13th Jul 20187:00 amRNSPlacing to raise £20 million
25th Jun 20187:00 amRNSFinal Results
18th May 201812:30 pmRNSAcquisition of Forest Environmental
24th Apr 20187:00 amRNSAcquisition of Island Fire Protection Limited
27th Mar 20187:00 amRNSAcquisition of Flamefast Fire Systems Limited
8th Feb 20187:00 amRNSAcquisition of Future Water Limited
12th Jan 20189:37 amRNSHolding(s) in Company
9th Jan 20187:00 amRNSHolding(s) in Company
5th Jan 20189:19 amRNSIssue of Equity
21st Dec 20177:00 amRNSAcquisition of Guardian Water Treatment Limited
11th Dec 20177:00 amRNSHalf-year Report
11th Dec 20177:00 amRNSAppointment of Group Finance Director
26th Oct 20177:00 amRNSAcquisition
24th Oct 20174:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.